摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-{5-[1-(2-Hydroxy-phenyl)-meth-(Z)-ylidene]-4-oxo-2-thioxo-thiazolidin-3-yl}-propionic acid | 7025-21-0

中文名称
——
中文别名
——
英文名称
3-{5-[1-(2-Hydroxy-phenyl)-meth-(Z)-ylidene]-4-oxo-2-thioxo-thiazolidin-3-yl}-propionic acid
英文别名
3-[(5Z)-5-(2-hydroxybenzylidene)-4-oxo-2-thioxo-1,3-thiazolidin-3-yl]propanoic acid;3-[(5Z)-5-[(2-hydroxyphenyl)methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]propanoic acid
3-{5-[1-(2-Hydroxy-phenyl)-meth-(Z)-ylidene]-4-oxo-2-thioxo-thiazolidin-3-yl}-propionic acid化学式
CAS
7025-21-0
化学式
C13H11NO4S2
mdl
——
分子量
309.367
InChiKey
HCAYBQDLEZXPGK-YFHOEESVSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.1
  • 重原子数:
    20
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.15
  • 拓扑面积:
    135
  • 氢给体数:
    2
  • 氢受体数:
    6

文献信息

  • Oxazole and thiazole compounds as beta-catenin modulators and uses thereof
    申请人:Dasgupta Ramanuj
    公开号:US20090227624A1
    公开(公告)日:2009-09-10
    A series of oxazole and thiazole compounds are shown herein to be small molecule inhibitors of the Wnt pathway that specifically target the activity of the stabilized pool of β-cat oxazole and thiazole compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, cancer, and others.
  • OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF
    申请人:DASGUPTA Ramanuj
    公开号:US20120264744A1
    公开(公告)日:2012-10-18
    A series of oxazole and thiazole compounds are shown herein to be small molecule inhibitors of the Wnt pathway that specifically target the activity of the stabilized pool of β-catenin. Oxazole and thiazole compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, cancer, and others.
  • US8252823B2
    申请人:——
    公开号:US8252823B2
    公开(公告)日:2012-08-28
  • US9173871B2
    申请人:——
    公开号:US9173871B2
    公开(公告)日:2015-11-03
  • US9433611B2
    申请人:——
    公开号:US9433611B2
    公开(公告)日:2016-09-06
查看更多